Nonclassic congenital adrenal hyperplasia

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 3, 2012, Pages 151-158

  Witchel, Selma Feldman ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

androgen; congenital adrenal hyperplasia; CYP21A2; hirsutism; premature pubarche

Indexed keywords

ANTIANDROGEN; CORTICOTROPIN; CYTOCHROME P450 REDUCTASE; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; ORAL CONTRACEPTIVE AGENT; PREDNISOLONE; PREDNISONE; PROGESTERONE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TETRACOSACTIDE;

ACNE; ADRENAL CORTEX TUMOR; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CORTICOSTEROID THERAPY; DISEASE COURSE; FERTILITY; HIRSUTISM; HUMAN; MOLECULAR GENETICS; NONCLASSIC CONGENITAL ADRENAL HYPERPLASIA; OLIGOSPERMIA; ONSET AGE; PATHOPHYSIOLOGY; PHENOTYPE; PRECOCIOUS PUBERTY; PREVALENCE; PROGESTERONE BLOOD LEVEL; REVIEW; STEROIDOGENESIS; TESTIS TUMOR;

ACNE VULGARIS; ADOLESCENT; ADOLESCENT DEVELOPMENT; ADRENAL HYPERPLASIA, CONGENITAL; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; FEMALE; HIRSUTISM; HUMANS; INDIVIDUALIZED MEDICINE; INFANT; INFERTILITY; MALE; MENSTRUATION; PUBERTY; STEROID 21-HYDROXYLASE;

EID: 84860741422     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283534db2     Document Type: Review

References (67)

1. Witchel SF, Azziz R. Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol 2011; 24:116-126.
2. Trakakis E, Loghis C, Kassanos D. Congenital adrenal hyperplasia because of 21-hydroxylase deficiency. A genetic disorder of interest to obstetricians and gynecologists. Obstet Gynecol Surv 2009; 64:177-189.
3. De Crecchio. Sopra un caso di apparenze virili in una donna. Morgagni 1865;7:154.
4. Decourt MJ, Jayle MF, Baulieu E. Virilisme cliniquement tardif avec excretion de pregnanetriol et insuffisance de la production du cortisol. Ann Endocrinol (Paris) 1957; 18:416-422.
5. Speiser PW, Dupont B, Rubinstein P, et al. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 37:650-667. (Pubitemid 16249426)
6. Wilson RC, Nimkarn S, Dumic M, et al. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab 2007; 90:414-421. (Pubitemid 46484429)
7. Witchel SF, Azziz R. Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010; 2010:625105.
8. Tardy V, Menassa R, Sulmont V, et al. Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and one carrier. J Clin Endocrinol Metab 2010; 95:1288-1300.
9. Concolino P, Mello E, Patrosso MC, et al. p.H282N and p.Y191H: 2 novel CYP21A2 mutations in Italian congenital adrenal hyperplasia patients. Metabolism 2012; 61:519-524.
10. Minutolo C, Nadra AD, Fernández C, et al. Structure-based analysis of five novel disease-causing mutations in 21-hydroxylase-deficient patients. PLoS One 2011; 6:e15899.
11. Concolino P, Mello E, Zuppi C, Capoluongo E. Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations. Clin Chem Lab Med 2010; 48:1057-1062.
12. Speiser PW, Dupont J, Zhu D, et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 1992; 90:584-595.
13. Wedell A, Ritzén EM, Haglund-Stengler B, Luthman H. Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations. Proc Natl Acad Sci U S A 1992; 89:7232-7236.
14. Jaaskelainen J, Levo A, Voutilainen R, Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab 1997; 82:3293-3297. (Pubitemid 27419074)
15. Robins T, Carlsson J, Sunnerhagen M, et al. Molecular model of human CYP21 based on mammalian CYP2C5: structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia. Mol Endocrinol 2006; 20:2946-2964. (Pubitemid 44834328)
16. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011; 32:81-151.
17. Huerta R, Dewailly D, Decanter C, et al. Adrenocortical hyper-responsivity to ACTH: a mechanism favoring the normal production of cortisol in 21-hydroxylase deficient nonclassic adrenal hyperplasia. Fertil Steril 2000; 74:329-334. (Pubitemid 30604199)
18. Sánchez LA, Morán C, Reyna R, et al. Adrenal progestogen and androgen production in 21-hydroxylase deficient nonclassic adrenal hyperplasia is partially independent of adrenocorticotropic hormone stimulation. Fertil Steril 2002; 77:750-753. (Pubitemid 34275356)
19. Azziz R, Slayden SM. The 21-hydroxylase-deficient adrenal hyperplasias: more than ACTH oversecretion. J Soc Gynecol Investig 1996; 3:297-302. (Pubitemid 26374244)
20. Ghayee HK, Auchus RJ. Basic concepts and recent developments in human steroid hormone biosynthesis. Rev Endocr Metab Disord 2007; 8:289-300.
21. Moran C, Azziz R, Carmina E, et al. 21-hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol 2000; 183:1468-1474. (Pubitemid 32061209)
22. Bidet M, Bellanné-Chantelot C, Galand-Portier MB, et al. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 2009; 94:1570-1578.
23. Concolino P, Vendittelli F, Mello E, et al. Functional analysis of two rare CYP21A2 mutations detected in Italian patients with a mildest form of congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2009; 71:470-476.
24. Nandagopal R, Sinaii N, Avila NA, et al. Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families. Eur J Endocrinol 2011; 164:977-984.
25. Wasniewska M, Raiola G, Galati MC, et al. Nonclassical 21-hydroxylase deficiency in boys with prepubertal or pubertal gynecomastia. Eur J Pediatr 2008; 167:1083-1084.
26. Nigawara T, Kageyama K, Sakihara S, et al. A male case of nonclassical 21-hydroxylase deficiency first manifested in his sixties with adrenocortical incidentaloma. Endocr J 2008; 55:291-297. (Pubitemid 351670953)
27. Idkowiak J, Lavery GG, Dhir V, et al. Premature adrenarche: novel lessons from early onset androgen excess. Eur J Endocrinol 2011; 165:189-207.
28. Armengaud JB, Charkaluk ML, Trivin C, et al. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. J Clin Endocrinol Metab 2009; 94:2835-2840.
29. Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95:4133-4160.
30. Caputo V, Fiorella S, Curiale S, et al. Refractory acne and 21-hydroxylase deficiency in a selected group of female patients. Dermatology 2010; 220:121-127.
31. Hatch R, Rosenfield RL, Kim MH, et al. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981; 140:815-830. (Pubitemid 11046650)
32. Levin JH, Carmina E, Lobo RA. Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adultonset congenital adrenal hyperplasia? Fertil Steril 1991 56 635-640.
33. Azziz R, Dewailly D, Owerbach D. Nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 1994; 78:810-815.
34. Pall M, Azziz R, Beires J, Pignatelli D. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertil Steril 2010; 94:684-689.
35. Barnes RB, Rosenfield RL, Ehrmann DA, et al. Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 1994; 79:1328-1333. (Pubitemid 24369843)
36. Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 2005 11 357-374. (Pubitemid 40895465)
37. Carmina E, Lobo RA. Ovarian suppression reduces clinical and endocrine expression of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Fertil Steril 1994; 62:738-743. (Pubitemid 24307567)
38. Blank SK, McCartney CR, Helm KD, Marshall JC. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin Reprod Med 2007; 25:352-359. (Pubitemid 47339159)
39. McGee W, Bishop C, Bahar A, et al. Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome. Human Reproduction 2012; 27:531-540.
40. Moran C, Azziz R, Weintrob N, et al. Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 2006; 91:3451-3456. (Pubitemid 44402118)
41. Stikkelbroeck NM, Sweep CG, Braat DD, et al. Monitoring of menstrual cycles, ovulation, and adrenal suppression by saliva sampling in female patients with 21-hydroxylase deficiency. Fertil Steril 2003; 80:1030-1036. (Pubitemid 37230044)
42. Casterà s A, De Silva P, Rumsby G, Conway GS. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf) 2009; 70:833-837.
43. Hofmann GE, Bentzien F, Bergh PA, et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril 1993; 60:675-679. (Pubitemid 23298514)
44. Kilicdag EB, Haydardedeoglu B, Cok T, et al. Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles. Arch Gynecol Obstet 2010; 281:747-752.
45. Falhammar H, Filipsson Nyström H, Ekström U, et al. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur J Endocrinol 2011; 166:441-449.
46. Reisch N, Flade L, Scherr M, et al. High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2009; 94:1665-1670.
47. Bidet M, Bellanné-Chantelot C, Galand-Portier M-B, et al. Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2010; 95:1182-1190.
48. Trakakis E, Dracopoulou-Vabouli M, Dacou-Voutetakis C, et al. Infertility reversed by glucocorticoids and full-term pregnancy in a couple with previously undiagnosed nonclassic congenital adrenal hyperplasia. Fertil Steril 2011; 96:1048-1050.
49. Verma S, Green-Golan L, VanRyzin C, et al. Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia. Horm Metab Res 2010; 42:607-612.
50. Rosencrantz MA, Coffler MS, Haggan A, et al. Clinical evidence for predominance of delta-5 steroid production in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2011; 96:1106-1113.
51. Soldin SJ, Soldin OP. Steroid hormone analysis by tandem mass spectrometry. Clin Chem 2009; 55:1061.
52. Shackleton C. Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis. J Steroid Biochem Mol Biol 2010; 121:481-490.
53. Escobar-Morreale HF, Sanchón R, San Millán JL. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 2008; 93:527.
54. Azziz R, Hincapie LA, Knochenhauer ES, et al. Screening for 21-hydroxylasedeficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 1999; 72:915.
55. Kleinle S, Lang R, Fischer GF, et al. Duplications of the functional CYP21A2 gene are primarily restricted to Q318X alleles: evidence for a founder effect. J Clin Endocrinol Metab 2009; 94:3954.
56. Lutfallah C, Wang W, Mason JI, et al. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 2002; 87:2611-2622. (Pubitemid 34655322)
57. Joehrer K, Geley S, Strasser-Wozak EM, Azziz R, et al. CYP11B1 mutations causing nonclassic adrenal hyperplasia due to 11b-hydroxylase deficiency. Hum Mol Genet 1997; 6:1829-1834. (Pubitemid 27460357)
58. Sahakitrungruang T, Huang N, Tee MK, et al. Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients. J Clin Endocrinol Metab 2009; 94:4992-5000.
59. Idkowiak J, O'Riordan S, Reisch N, et al. Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. J Clin Endocrinol Metab 2011; 96:E453-E462.
60. Sahakitrungruang T, Soccio RE, Lang-Muritano M, et al. Clinical, genetic, and functional characterization of four patients carrying partial loss-of-function mutations in the steroidogenic acute regulatory protein (StAR). J Clin Endocrinol Metab 2010; 95:3352-3359.
61. Metherell LA, Naville D, Halaby G, et al. Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. J Clin Endocrinol Metab 2009; 94:3865-3871.
62. Trapp CM, Oberfield SE. Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update. Steroids 2012; 77:342-346.
63. Auchus RJ. Congenital adrenal hyperplasia in adults. Curr Opin Endocrinol Diabetes Obes 2010; 17:210-216.
64. Merke DP. Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2008; 93:653-660. (Pubitemid 351398534)
65. Claahsen-van der Grinten HL, Stikkelbroeck NM, Otten BJ, Hermus AR. Congenital adrenal hyperplasia: pharmacologic interventions from the prenatal phase to adulthood. Pharmacol Ther 2011; 132:1-14.
66. Clayton PE, Miller WL, Oberfield SE, et al., Speiser PW; ESPE/LWPES CAH Working Group. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res 2002; 58:188-195.
67. Azziz R, Koulianos G. Adrenal androgens and reproductive aging in females. Sem Reprod Endo 1991; 9:249-260.